We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Investigation and assessment of adrenal incidentalomas.
- Authors
Cuthbertson, Daniel J.; Alam, Uazman; Davison, Andrew S.; Belfield, Jane; Shore, Susannah L.; Vinjamuri, Sobhan
- Abstract
With the increasing volume of diagnostic imaging undertaken in an ageing population, adrenal incidentalomas (AIs) are increasingly commonly seen. These masses are most likely to be benign, but a small proportion may be malignant. Similarly, they are usually non-functional, but ~14% are functional, ie hormone-secreting tumours. Clinical, biochemical and radiological assessment is mandated to stratify patients into those requiring radiological surveillance, medical management or surgical intervention or who can be discharged. Mass characteristics on cross-sectional (CT/MRI) imaging influence the need for radiological surveillance. Functional tumours where excess cortisol, aldosterone or catecholamine are secreted should be excluded, with mild autonomous cortisol secretion (MACS) and primary aldosteronism (PA) as the two most common functional states. MACS and PA are associated with an increased risk of cardiometabolic disease (eg hypertension, type 2 diabetes) and cardiovascular morbidity/mortality (eg coronary heart disease). Multidisciplinary management is critical for selected cases; the majority of adrenal incidentalomas only require a single assessment.
- Subjects
HORMONE metabolism; CARDIOVASCULAR disease related mortality; BIOCHEMISTRY; CARDIOVASCULAR diseases risk factors; CLASSIFICATION; CATECHOLAMINES; CONTINUING education units; PATIENTS; DISEASES; DIAGNOSTIC imaging; HYPERALDOSTERONISM; HEALTH care teams; SYMPTOMS; ADRENAL tumors; ALDOSTERONE; HYDROCORTISONE; DISEASE complications
- Publication
Clinical Medicine, 2023, Vol 23, Issue 2, p135
- ISSN
1470-2118
- Publication type
Article
- DOI
10.7861/clinmed.2023-0042